Between suppliers and manufacturers, planning for the termination of a supply agreement during its negotiation may seem counterintuitive, awkward, or perhaps insignificant. Termination discussions often take a back seat in the conference room where the negotiating energy is spent primarily on price, quality, and delivery terms. As one court observed, termination is typically “of little interest or concern to the parties” so long as they
Read More Termination for Convenience Under the Uniform Commercial CodeWiggin and Dana
New Guidance on Providing Financial Services to Medical Marijuana Businesses
Posted on
Connecticut recently awarded licenses to four medical marijuana producers, marking the beginning of Connecticut’s legal medical marijuana industry. Although medical marijuana businesses are licensed and heavily regulated by the State of Connecticut,[1] they have had difficulty securing basic financial services due to ambiguities in federal policy. Financial institutions are wary of servicing such clients owing to the requirements of the Bank Secrecy Act and…
Read More New Guidance on Providing Financial Services to Medical Marijuana BusinessesFederal Trade Commission Expands Requirements for Reporting Pharmaceutical Patent License Transactions
Posted on
Upcoming revisions to the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) will result in numerous additional pharmaceutical licensing transactions becoming subject to filing requirements under the HSR Act. On November 6, the U.S. Federal Trade Commission (the “FTC”) released the final version of amendments to be made to the HSR Act. The amendments will impact the analysis of whether parties to…
Read More Federal Trade Commission Expands Requirements for Reporting Pharmaceutical Patent License Transactions